dactinomycin has been researched along with Atypical Ductal Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connelly, RR; Moldow, RE | 1 |
| Eylan, E; Gazith, A; Izsak, FC; Naharin, S; Raanani, C; Shapiro, J | 1 |
2 other study(ies) available for dactinomycin and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
Epidemiology of pancreatic cancer in Connecticut.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Black People; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Connecticut; Cystadenocarcinoma; Dactinomycin; Family Characteristics; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pancreatic Neoplasms; Prognosis; Religion; Residence Characteristics; Seasons; Sex Factors; Thiotepa; White People | 1968 |
Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Papillary; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; In Vitro Techniques; Middle Aged; Nucleic Acids; Phosphorus Isotopes; Stomach Neoplasms; Thiotepa; Vincristine | 1971 |